Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Special Federal Task Force Needed To Head Off Medicare Drug Fraud, Sen. Grassley Says

This article was originally published in The Pink Sheet Daily

Executive Summary

The inter-agency task force would consist of representatives from CMS, HHS and the Justice Department. CMS head McClellan says he supports working across agencies to address Medicare fraud and abuse.

You may also be interested in...



HHS Inspector General To Publish Medicare Card Program Civil Penalties Rule

The interim final rule will be published the week of May 17. CMS is closely monitoring drug card pricing changes to prevent “bait and switch” tactics.

Employer Options For Retiree Health Plans Outlined In Proposed Medicare Drug Rule

CMS is declining to predict whether the four retiree health coverage options available to employers and outlined in a Medicare proposed rule issued July 26 will be sufficient to stem the tide of employer dropouts

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059206

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel